logo-loader
CVE:BCT

Briacell Therapeutics Corp

Receive alerts
Market:
CVE
Market Cap:
$10.8 m
Price
$0.06
Change
0.00%
52 weeks high
0.15
52 weeks low
0.06

In brief

BriaCell is a clinical stage immuno-oncology focused biotechnology company developing the first off-the-shelf personalized immunotherapy targeting advanced breast cancer.